LAW; Che-Leung

Patent Applications and Registrations

Patent applications and USPTO patent grants for LAW; Che-Leung.The latest application filed is for "dosage and administration of non-fucosylated anti-cd40 antibody".

Company Profile

4.27.43

LAW; Che-Leung - Shoreline WA
LAW; Che-Leung - Seattle WA
Law; Che-Leung - Bothell WA
Law; Che-Leung - North Shoreline WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibody App 20220265822 - Gardai; Shyra ; et al.	2022-08-25
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20220249662 - Gardai; Shyra ; et al.	2022-08-11
Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen App 20220241403 - CLARK; Edward A. ; et al.	2022-08-04
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV PreS1 and/or PreS2, and/or s-HBsAg regions of the HBV envelope protein Grant 11,389,532 - Clark , et al. July 19, 2	2022-07-19
Anti-NTB-A antibodies and related compositions and methods Grant 11,351,269 - Lewis , et al. June 7, 2	2022-06-07
Therapeutic vaccine for Hepatitis b virus (HBV) using the HBV core antigen Grant 11,324,819 - Clark , et al. May 10, 2	2022-05-10
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant 11,213,584 - Gardai , et al. January 4, 2	2022-01-04
Dosage and administration of non-fucosylated anti-CD40 antibodies Grant 11,202,827 - Gardai , et al. December 21, 2	2021-12-21
A Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV PreS1 and/or PreS2, and/or S-HBsAg regions of the HBV envelope protein App 20200345838 - CLARK; Edward A. ; et al.	2020-11-05
Therapeutic Vaccine for Hepatitis B Virus (HBV) using the HBV Core Antigen App 20200306367 - CLARK; Edward ; et al.	2020-10-01
Anti-ntb-a Antibodies And Related Compositions And Methods App 20190375841 - Lewis; Timothy S. ; et al.	2019-12-12
Anti-NTB-A antibodies and related compositions and methods Grant 10,435,468 - Lewis , et al. O	2019-10-08
Synergistic Effects Between Auristatin-based Antibody Drug Conjugates And Inhibitors Of The Pi3k-akt Mtor Pathway App 20190184029 - Lewis; Timothy S. ; et al.	2019-06-20
Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway Grant 10,201,615 - Lewis , et al. Feb	2019-02-12
Cancer Treatment Using 2-deoxy-2-fluoro-l-fucose In Combination With A Checkpoint Inhibitor App 20180353524 - Gardai; Shyra ; et al.	2018-12-13
Anti-ntb-a Antibodies And Related Compositions And Methods App 20180169257 - Lewis; Timothy ; et al.	2018-06-21
Combination Therapy Using A Cd19-adc And Vincristine App 20180028681 - Law; Che-Leung ; et al.	2018-02-01
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20170333556 - Gardai; Shyra ; et al.	2017-11-23
Anti-ntb-a Antibodies And Related Compositions And Methods App 20170320944 - Lewis; Timothy S. ; et al.	2017-11-09
Anti-NTB-A antibodies and related compositions and methods Grant 9,708,404 - Lewis , et al. July 18, 2	2017-07-18
Dosage And Administration Of Non-fucosylated Anti-cd40 Antibodies App 20170137528 - Gardai; Shyra ; et al.	2017-05-18
Synergistic Effects Between Auristatin-based Antibody Drug Conjugates And Inhibitors Of The Pi3k-akt Mtor Pathway App 20160220693 - Lewis; Timothy S. ; et al.	2016-08-04
Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates Grant 9,345,785 - Law , et al. May 24, 2	2016-05-24
Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathway Grant 9,272,052 - Lewis , et al. March 1, 2	2016-03-01
Anti-ntb-a Antibodies And Related Compositions And Methods App 20150376276 - Lewis; Timothy S ; et al.	2015-12-31
Anti-CD70 antibody and its use for the treatment of cancer and immune disorders Grant 9,051,372 - Law , et al. June 9, 2	2015-06-09
Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders Grant 8,663,642 - Law , et al. March 4, 2	2014-03-04
Treatment of immune disorders with anti-CD70 antibody Grant 8,647,624 - Law , et al. February 11, 2	2014-02-11
Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates Grant 8,609,104 - Law , et al. December 17, 2	2013-12-17
Humanized anti-CD70 binding agents and uses thereof Grant 8,562,987 - McDonagh , et al. October 22, 2	2013-10-22
Synergistic Effects Between Auristatin-Based Antibody Drug Conjugates And Inhibitors Of The PI3K-AKT mTOR Pathway App 20130209496 - Lewis; Timothy S. ; et al.	2013-08-15
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders Grant 8,337,838 - Law , et al. December 25, 2	2012-12-25
Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders App 20120294863 - Law; Che-Leung ; et al.	2012-11-22
Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders App 20120288512 - Law; Che-Leung ; et al.	2012-11-15
Treatment of B-Cell Cancers With Anti-CD70 Antibody-Drug Conjugates App 20120251559 - Law; Che-Leung ; et al.	2012-10-04
Humanized Anti-CD70 Binding Agents and Uses Thereof App 20120045436 - McDonagh; Charlotte ; et al.	2012-02-23
Humanized anti-CD70 binding agents and uses thereof Grant 8,067,546 - McDonagh , et al. November 29, 2	2011-11-29
Anti-cd70 Antibody-drug Conjugates And Their Use For The Treatment And Prevention Of Cancer And Immune Disorders App 20110150908 - LAW; CHE-LEUNG ; et al.	2011-06-23
Anti-cd70 Antibody-drug Conjugates And Their Use For The Treatment Of Cancer And Immune Disorders App 20100183636 - Law; Che-leung ; et al.	2010-07-22
Treatment Of Renal Cell Carcinoma With Anti-cd70 Antibody-drug Conjugates App 20100158910 - Law; Che-Leung ; et al.	2010-06-24
Treatment Of B-cell Cancers With Anti-cd70 Antibody-drug Conjugates App 20100150925 - Law; Che-Leung ; et al.	2010-06-17
Treatment Of Psoriatic Arthritis With Anti-cd70 Antibody App 20100129362 - LAW; CHE-LEUNG ; et al.	2010-05-27
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders Grant 7,662,387 - Law , et al. February 16, 2	2010-02-16
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders Grant 7,641,903 - Law , et al. January 5, 2	2010-01-05
Methods Of Using Cd40 Binding Agents App 20090304687 - Drachman; Jonathan ; et al.	2009-12-10
Anti-CD70 Antibody And Its Use For The Treatment And Prevention Of Cancer And Immune Disorders App 20090232806 - Law; Che-Leung ; et al.	2009-09-17
Humanized Anti-cd70 Binding Agents And Uses Thereof App 20090148942 - McDonagh; Charlotte ; et al.	2009-06-11
Anti-CD70 Antibody and Its Use for the Treatment of Cancer and Immune Disorders App 20090074772 - Law; Che-Leung ; et al.	2009-03-19
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders Grant 7,491,390 - Law , et al. February 17, 2	2009-02-17
Anti-cd70 Antibody And Its Use For The Treatment Of Cancer And Immune Disorders App 20080138343 - Law; Che-Leung ; et al.	2008-06-12
Anti-CD70 antibody and its use for the treatment of cancer and immune disorders App 20080138341 - Law; Che-Leung ; et al.	2008-06-12
Anti-cd70 Antibody-drug Conjugates And Their Use For The Treatment Of Cancer And Immune Disorders App 20080025989 - Law; Che-Leung ; et al.	2008-01-31
Anti-cd70 Antibody And Its Use For The Treatment And Prevention Of Cancer And Immune Disorders App 20070292422 - Law; Che-Leung ; et al.	2007-12-20
Sga-1m, a cancer associated antigen, and uses thereof App 20070128593 - Petroziello; Joseph M. ; et al.	2007-06-07
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders App 20060233794 - Law; Che-Leung ; et al.	2006-10-19
Cancer associated antigens, sga-56m and sga-56mv, and uses thereof App 20060121476 - Petroziello; Joseph M. ; et al.	2006-06-08
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders App 20060083736 - Law; Che-Leung ; et al.	2006-04-20
Compositions and methods for regulating lymphocyte activation App 20050261478 - Ledbetter, Jeffrey A. ; et al.	2005-11-24
Anti-CD20 antibody-drug conjugates for the treatment of cancer and immune disorders App 20050180972 - Wahl, Alan F. ; et al.	2005-08-18
Treatment of immunological disorders using anti-dc30 antibodies App 20050123536 - Law, Che-Leung ; et al.	2005-06-09
Compositions and methods for regulating lymphocyte activation App 20040253250 - Ledbetter, Jeffrey A. ; et al.	2004-12-16
Compositions And Methods For Regulating Lymphocyte Activation App 20020155604 - LEDBETTER, JEFFREY A. ; et al.	2002-10-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.